Ds. Elmer et al., USE OF GLUCOSE DISAPPEARANCE RATES (K(G)) TO MONITOR ENDOCRINE FUNCTION OF PANCREAS ALLOGRAFTS, Clinical transplantation, 12(1), 1998, pp. 56-64
We have reported that a decline in glucose disappearance rate (k(G)) i
n pancreas transplant recipients is associated with pancreatic rejecti
on, The purpose of this study was to determine test-retest reliability
of k(G) monitoring and to establish the k(G) criteria for diagnosing
abnormal graft function. Six healthy non-diabetic volunteers and 14 st
able pancreas recipients underwent 2 intravenous glucose tolerance tes
ts 7 d apart. All k(G) values in non-diabetic volunteers had < 15% var
iation between the two determinations (r = 0.96, P less than or equal
to 0.0006), Similarly, 13/14 recipients experienced < 20% variation in
k(G) with one patients experiencing a 23% variation (r = 0.90, P less
than or equal to 0.0001). Using a 20% change from baseline as the ref
erence value, we monitored 28 pancreas recipients for 2-36 months post
-transplant. Of 253 k(G) values, 160 (64%) did not exceed the 20% chan
ge from baseline, 65 (26%) declined > 20% and 28 (11%) increased > 20%
. Of 160 stable k(G) values, 154 (96%) were associated with normal gra
ft function while 6 (4%) occurred in the context of rejection. Of 65 k
(G) values declining by greater than or equal to 20%, 47 (72%) accurat
ely identified acute rejections diagnosed by biopsy (70%) or response
to treatment (30%), 12 (19%) were associated with identifiable causes
of increased insulin resistance and only in 6 (9%) cases a cause for t
he decline was unidentifiable. The k(G) values with > 20% rise from ba
seline were, in 15%, associated with identifiable causes of decreased
insulin resistance. The sensitivity of the k(G) as a marker for reject
ion was 88.7%, specificity 91%, positive predictive value 72.3%, negat
ive predictive value 96.8%, and accuracy 90.5%, These data confirm tha
t a > 20% deterioration of glucose disappearance rate is associated wi
th pancreas allograft rejection, and confirms the utility of k(G) moni
toring in clinical follow-up of pancreas transplant recipients.